Show simple item record

dc.contributor.authorMcAleer, M A
dc.contributor.authorBourke, J
dc.date.accessioned2012-02-01T10:43:00Z
dc.date.available2012-02-01T10:43:00Z
dc.date.issued2012-02-01T10:43:00Z
dc.identifier.citationClin Exp Dermatol. 2011 Aug;36(6):638-40. doi: 10.1111/j.1365-2230.2011.04039.x.en_GB
dc.identifier.issn1365-2230 (Electronic)en_GB
dc.identifier.issn0307-6938 (Linking)en_GB
dc.identifier.pmid21771010en_GB
dc.identifier.doi10.1111/j.1365-2230.2011.04039.xen_GB
dc.identifier.urihttp://hdl.handle.net/10147/207775
dc.description.abstractHuman papilloma virus is a common and often distressing cutaneous disease. It can be therapeutically challenging, especially in immunocompromised patients. We report a case of recalcitrant cutaneous warts that resolved with intravenous cidofovir treatment. The patient was immunocompromised secondary to monoclonal antibody therapy for psoriasis.
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAntibodies, Monoclonal/therapeutic useen_GB
dc.subject.meshAntibodies, Monoclonal, Humanizeden_GB
dc.subject.meshAntiviral Agents/*administration & dosageen_GB
dc.subject.meshCytosine/administration & dosage/*analogs & derivativesen_GB
dc.subject.meshHumansen_GB
dc.subject.mesh*Immunocompromised Hosten_GB
dc.subject.meshInfusions, Intravenousen_GB
dc.subject.meshMaleen_GB
dc.subject.meshPhosphonic Acids/*administration & dosageen_GB
dc.subject.meshPsoriasis/*therapyen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.subject.meshTumor Necrosis Factor-alpha/therapeutic useen_GB
dc.subject.meshWarts/*drug therapyen_GB
dc.titleIntravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.en_GB
dc.contributor.departmentDepartment of Dermatology, South Infirmary-Victoria University Hospital, Cork,, Co. Cork, Ireland.en_GB
dc.identifier.journalClinical and experimental dermatologyen_GB
dc.description.provinceMunster
html.description.abstractHuman papilloma virus is a common and often distressing cutaneous disease. It can be therapeutically challenging, especially in immunocompromised patients. We report a case of recalcitrant cutaneous warts that resolved with intravenous cidofovir treatment. The patient was immunocompromised secondary to monoclonal antibody therapy for psoriasis.


This item appears in the following Collection(s)

Show simple item record